What is Patheon Pharma Services?
Headquartered in Durham, North Carolina, and established in 1974, Patheon Pharma Services operates as a premier contract development and manufacturing organization (CDMO). The company specializes in the end-to-end production of active pharmaceutical ingredients (APIs), oral solid doses, gels, and sterile solutions. By providing comprehensive manufacturing and development services, Patheon enables pharmaceutical companies to accelerate their time-to-market for critical therapies. Its integration into the Thermo Fisher Scientific ecosystem has further solidified its reputation as a high-authority provider of scalable, high-quality pharmaceutical solutions, serving a diverse portfolio of global clients ranging from emerging biotech firms to established multinational corporations.
How much funding has Patheon Pharma Services raised?
Patheon Pharma Services has raised a total of $625M across 1 funding round:
Stock Offering
$625M
Stock Issuance/Offering (2016): $625M, investors not publicly disclosed
Key Investors in Patheon Pharma Services
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Patheon Pharma Services?
With the recent strategic investment, Patheon Pharma Services is well-positioned to enhance its operational capacity and technological capabilities. The focus moving forward will likely center on expanding its sterile manufacturing footprint and integrating advanced digital manufacturing processes to improve efficiency and compliance. As the pharmaceutical industry faces increasing pressure to optimize supply chains and reduce development timelines, Patheon's ability to provide reliable, large-scale production will be a key driver of its future performance. The company is expected to continue its trajectory of innovation, potentially exploring new modalities in drug delivery and specialized manufacturing to maintain its competitive edge in the global CDMO market.
See full Patheon Pharma Services company page
